BICARA THERAPEUTICS INC (BCAX) Stock News

NASDAQ:BCAX - Nasdaq - US0554771032 - Common Stock - Currency: USD

10.2 0 (0%)

After market: 10.2 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BCAX Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Relay Therapeutics, Inc. - Mentions: RLAY

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

2 months ago - By: Benzinga - Mentions: BOLT CLRB MESO CBUS ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

2 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

2 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

2 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025

2 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025

2 months ago - By: Yahoo Finance - Mentions: NRXP USB JAKK IVR ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network

2 months ago - By: Yahoo Finance - Mentions: MS CPNG TGT CRM ...

Morgan Stanley Names Coupang (CPNG) Its New Top Pick, Lifts PT

2 months ago - By: Yahoo Finance - Mentions: MS GMED MDT SE ...

Morgan Stanley Maintains Buy Rating on Bicara (BCAX) After the Ficerafusp Alfa Trial Update

3 months ago - By: Yahoo Finance - Mentions: MS NIO TSLA RZB ...

Morgan Stanley Maintains Buy rating on NIO Inc (NIO)

3 months ago - By: Yahoo Finance

Stifel Reaffirms Buy Rating on BCAX After Promising ASCO Data for HPV-Negative Patients

3 months ago - By: Benzinga

Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?

3 months ago - By: Investor's Business Daily - Mentions: MRUS MRK

Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics

3 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting

3 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting

3 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

3 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

3 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025

3 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025

4 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics to Present Updated Data from Ongoing Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

4 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics to Present Updated Data from Ongoing Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

5 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

5 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

5 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2025

5 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2025

6 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

6 months ago - By: Bicara Therapeutics Inc.

Bicara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference